• GLP-1 Companion Services: GLP-1 medications like Ozempic and Mounjaro are in high demand and can deliver benefits such as quicker weight loss, lower blood sugar levels, lower blood pressure, but they also come with significant complications such as gastroparesis, intestinal obstruction, pancreatitis, muscle loss, mental health issues, and even cancer. Also, while payers are spending enormous sums on GLP-1s, unless these medications are blended with healthier lifestyle changes, the weight – and health risks – soon return, negating any benefit they may yield.
But HabitNu’s GLP-1 “step-up / step-down” app boosts GLP-1 adherence, manages side effects, and supports long-term health maintenance, enabling patients to eliminate their need for the medication – while keeping the weight off for the long-term!
By combining real-time support with behavioral reinforcement, HabitNu helps patients succeed beyond the prescription period, improving outcomes and lowering overall healthcare costs through sustained engagement and smarter, more effective use of medication.